NAFDAC blames India and China for fake drug

12 January 2009

Nigeria's National Agency for Food and Drug Administration and Control has blamed counterfeit drug manufacturers in India and China for the  contamination of 3,000 bottles of a teething formula which allegedly  contained 90% diethylene glycol. The additive is a poisonous ingredient  associated with recent tainted Chinese medicines, toothpaste and food  products in several countries, including the USA and Panama. In the  latter country, over 110 people died from tainted antihistamines and  cough remedies associated with the fake ingredient, that was  substituted for propylene glycolis (Marketletter June 18, 2007).

The contaminant is used for anti-freeze and brake fluid. The local  manufacturer of the affected over-the-counter product, My Pikin Baby  Teething Mixture, Lagos-based Barewa Pharmaceuticals, has been closed  down by the NAFDAC (Marketletter December 15, 2008). A similar case in  1990 led to about 200 infant deaths, the current fake drug incident has  so far claimed at least 30 lives, according to local reports.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight